PL3924518T3 - Obecne w ślinie biomarkery urazu mózgu - Google Patents

Obecne w ślinie biomarkery urazu mózgu

Info

Publication number
PL3924518T3
PL3924518T3 PL20708645.5T PL20708645T PL3924518T3 PL 3924518 T3 PL3924518 T3 PL 3924518T3 PL 20708645 T PL20708645 T PL 20708645T PL 3924518 T3 PL3924518 T3 PL 3924518T3
Authority
PL
Poland
Prior art keywords
brain injury
salivary biomarkers
salivary
biomarkers
brain
Prior art date
Application number
PL20708645.5T
Other languages
English (en)
Inventor
Antonio BELLI
Valentina Di Pietro
Original Assignee
Marker Diagnostics Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marker Diagnostics Uk Limited filed Critical Marker Diagnostics Uk Limited
Publication of PL3924518T3 publication Critical patent/PL3924518T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL20708645.5T 2019-02-14 2020-02-14 Obecne w ślinie biomarkery urazu mózgu PL3924518T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962805761P 2019-02-14 2019-02-14
US201962884104P 2019-08-07 2019-08-07
PCT/IB2020/051273 WO2020165863A2 (en) 2019-02-14 2020-02-14 Salivary biomarkers of brain injury

Publications (1)

Publication Number Publication Date
PL3924518T3 true PL3924518T3 (pl) 2025-08-11

Family

ID=69740439

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20708645.5T PL3924518T3 (pl) 2019-02-14 2020-02-14 Obecne w ślinie biomarkery urazu mózgu

Country Status (22)

Country Link
US (1) US20220380850A1 (pl)
EP (2) EP3924518B1 (pl)
JP (2) JP7738481B2 (pl)
KR (1) KR20220002867A (pl)
AU (1) AU2020220963A1 (pl)
BR (1) BR112021015845A2 (pl)
CA (1) CA3129034A1 (pl)
CL (1) CL2021002121A1 (pl)
CO (1) CO2021011964A2 (pl)
CR (1) CR20210466A (pl)
ES (1) ES3032948T3 (pl)
GE (2) GEAP202515717A (pl)
IL (1) IL285446A (pl)
MX (1) MX2021009829A (pl)
MY (1) MY207449A (pl)
PE (1) PE20220877A1 (pl)
PH (1) PH12021551945A1 (pl)
PL (1) PL3924518T3 (pl)
SG (1) SG11202108664RA (pl)
TW (1) TW202045734A (pl)
WO (1) WO2020165863A2 (pl)
ZA (2) ZA202106673B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
IL307369A (en) * 2021-04-02 2023-11-01 Marker Holdings Ag Biomarkers of muscle and skeletal injury
CN119193819B (zh) * 2024-11-28 2025-05-13 苏州麦锐克生物科技有限公司 用于阿尔茨海默病诊断的多重miRNA标志物及试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774173A1 (en) * 2009-09-14 2011-03-17 Banyan Biomarkers, Inc. Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
WO2015134551A1 (en) * 2014-03-03 2015-09-11 Banyan Biomarkers, Inc. Micro rna markers for diagnosis of a neurological condition
US11053545B2 (en) * 2015-09-08 2021-07-06 The Translational Genomics Research Institute Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
JP2020512017A (ja) * 2017-03-23 2020-04-23 クアドラント、バイオサイエンシズ、インコーポレイテッドQuadrant Biosciences Inc. 外傷性脳傷害及び脳震盪症状の分析及び予測

Also Published As

Publication number Publication date
CR20210466A (es) 2022-02-08
CO2021011964A2 (es) 2021-12-10
WO2020165863A3 (en) 2020-09-24
EP3924518B1 (en) 2025-04-16
WO2020165863A2 (en) 2020-08-20
IL285446A (en) 2021-09-30
US20220380850A1 (en) 2022-12-01
ZA202308936B (en) 2025-12-17
MY207449A (en) 2025-02-27
MX2021009829A (es) 2021-12-10
AU2020220963A1 (en) 2021-09-02
JP2022520427A (ja) 2022-03-30
CA3129034A1 (en) 2020-08-20
KR20220002867A (ko) 2022-01-07
PH12021551945A1 (en) 2022-05-23
EP4578961A3 (en) 2025-12-24
BR112021015845A2 (pt) 2021-10-05
EP3924518C0 (en) 2025-04-16
JP2025106509A (ja) 2025-07-15
EP3924518A2 (en) 2021-12-22
CL2021002121A1 (es) 2022-03-25
EP4578961A2 (en) 2025-07-02
JP7738481B2 (ja) 2025-09-12
TW202045734A (zh) 2020-12-16
PE20220877A1 (es) 2022-05-27
GEP20257829B (en) 2025-11-25
GEAP202515717A (en) 2025-06-10
SG11202108664RA (en) 2021-09-29
ZA202106673B (en) 2024-02-28
ES3032948T3 (en) 2025-07-29

Similar Documents

Publication Publication Date Title
ZA201805982B (en) Biomarkers of traumatic brain injury
GB2590844B (en) Simplified cross component prediction
CA197776S (en) Shaver
IL250123B (en) Detection of split signals
IL285446A (en) Salivary biomarkers of brain injury
GB201806072D0 (en) Methods of manufacture
GB201719639D0 (en) Setection of biomarkers
GB201806002D0 (en) Methods of spectroscopic analysis
GB201910188D0 (en) Analyser
GB201804648D0 (en) Combination biomarker
GB201902449D0 (en) Range prediction
IL276107A (en) Crystalline forms of psoorstam
GB202205329D0 (en) Traumatic brain injury detection
GB201918824D0 (en) Analysing surfaces of vehicles
GB2575067B (en) Selection of identifiers
ZA202105399B (en) Use of spiropidion
HK40114664A (zh) 创伤性脑损伤的生物标志物
PT3901141T (pt) Nova forma de isoquinolinossulfonamida
ZAF201800949S (en) Set of covers
ZAF201800950S (en) Set of covers
ZAF201800948S (en) Set of covers
GB201809075D0 (en) Instrument of formalisation
GB201721723D0 (en) Biomarkers of impaired health
GB201808405D0 (en) Instrument of formalisation
GB201802516D0 (en) Flyers